companydata.dkcompanydata.dk

ABIGO PHARMA A/S: Financial statements 2023

CVR: 12927983

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

ABIGO PHARMA A/S (CVR 12927983) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. That is a decrease of 28.7% compared with the year before. The profit margin was 2.2%. Equity in the 2023 report amounted to DKK 4,838,794. The solvency ratio was 80.9%. The company had 1 employee in the financial year.

Revenue
DKK 9,189,036
Gross Profit
DKK 1,095,740
Profit/Loss
DKK 201,721
Equity
DKK 4,838,794
Total Assets
DKK 5,982,815
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20239.2 mio.1.1 mio.202 t.4.8 mio.1
202212.9 mio.3.5 mio.166 t.4.6 mio.4
2021-12.9 mio.4.6 mio.4.5 mio.7
2020-6.2 mio.155 t.-159 t.8
2019-5.8 mio.-146 t.-314 t.8

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Erik Johan Brobjer joins the board of ABIGO PHARMA A/SOct 3, 2023

As of October 3, 2023, Erik Johan Brobjer has joined the board of directors of ABIGO PHARMA A/S.

Fredrik Ralph Stenbäcker leaves the board of ABIGO PHARMA A/SOct 3, 2023

As of October 3, 2023, Fredrik Ralph Stenbäcker has left the board of directors of ABIGO PHARMA A/S.

Ulrika Wictoria Wilson joins ABIGO PHARMA A/S as chairmanOct 3, 2023

As of October 3, 2023, Ulrika Wictoria Wilson is registered as chairman of ABIGO PHARMA A/S.

Erik Johan Brobjer joins ABIGO PHARMA A/S as adm. dir.Oct 3, 2023

As of October 3, 2023, Erik Johan Brobjer is registered as adm. dir. of ABIGO PHARMA A/S.

Johan Lindberg steps down as chairman of ABIGO PHARMA A/SOct 3, 2023

As of October 3, 2023, Johan Lindberg has stepped down as chairman of ABIGO PHARMA A/S.

Fredrik Ralph Stenbäcker steps down as adm. dir. of ABIGO PHARMA A/SOct 3, 2023

As of October 3, 2023, Fredrik Ralph Stenbäcker has stepped down as adm. dir. of ABIGO PHARMA A/S.

ABIGO PHARMA A/S: The 2022 annual report is outJun 12, 2023

ABIGO PHARMA A/S has published its annual report for 2022. Revenue came to DKK 12,886,055, and the net result was DKK 165,903.

About ABIGO PHARMA A/S

ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989. The company has been dissolved on 27 June 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named DHC A/S and DANSK HELSEMIDDEL CENTER A/S. The company has 1 employee (2023). In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity in the 2023 report amounted to DKK 4,838,794.

Source: annual report 2023, Danish Business Authority